Results 191 to 200 of about 67,342 (249)

Therapeutic targeting at genome mutations of liver cancer by the insertion of HSV1 thymidine kinase through Cas9-mediated editing. [PDF]

Hepatol Commun
Kader M, Sun W, Ren BG, Yu YP, Tao J, Foley LM, Liu S, Monga SP, Luo JH.   +8 more
europepmc   +1 more source

Serum thymidine kinase 1 protein concentrations and presence of its autoantibody as biomarkers for screening dogs with malignant tumors. [PDF]

J Vet Intern Med
Kim Y, Park J, Kim B, Yu KR, Kim HS, Oh Y, Seo K, Ryu M, Park C, Bhang D, Choi U, Youn H.   +11 more
europepmc   +1 more source

Thymidine Kinase Measurement [PDF]

, 2020
openaire   +1 more source

Combination of prostate cancer antigen 3 (PCA3), sarcosine, glypican-1 (GPC1), urokinase plasminogen activator receptor (uPAR), and thymidine kinase 1 (TK1), and T2WI and DWI radiomics model for distinguishing benign prostatic hyperplasia, prostate cancer, and prostatitis. [PDF]

J Med Biochem
Yang F, Guo W, Sun S, Huang Y.
europepmc   +1 more source

Analysis of antiviral drug properties of thymidine kinase of herpes B virus using recombinant herpes simplex virus 1. [PDF]

Microbiol Spectr
Nguyen PHA, Fukushi S, Yamada S, Harada S, Yoshikawa T, Kinoshita H, Kawahara M, Ogawa T, Ebihara H, Moi ML, Saijo M.   +10 more
europepmc   +1 more source

Nomogram model of serum thymidine kinase 1 combined with ultrasonography for prediction of central lymph node metastasis risk in patients with papillary thyroid carcinoma pre-surgery. [PDF]

Front Endocrinol (Lausanne)
Song X, Skog S, Wei L, Qin J, Yang R, Li J, Zhou J, He E, Zhou J.   +8 more
europepmc   +1 more source

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial. [PDF]

Breast Cancer Res Treat
Zhu Y, Zerdes I, Matikas A, Cruz IR, Bergqvist M, Elinder E, Bosch A, Lindman H, Einbeigi Z, Andersson A, Carlsson L, Dreifaldt AC, Isaksson-Friman E, Hellstrom M, Johansson H, Wang K, Bergh JCS, Hatschek T, Foukakis T.   +18 more
europepmc   +1 more source

A Novel Model Using Serum Thymidine Kinase 1 and Low-dose Computed Tomography Parameters to Predict Three-year Lung Cancer Risk in People with Pulmonary Nodules: A Retrospective Study. [PDF]

J Cancer
Yao B, Huang X, Wu F, Li J, He E, Li X, Zhang M, Zhou J, Hong H, Skog S, Wang H.   +10 more
europepmc   +1 more source

Mitochondrial Thymidine Kinase Inhibitors

Current Topics in Medicinal Chemistry, 2005
Mitochondrial thymidine kinase or TK-2 belongs to the family of mammalian deoxynucleoside kinases (dNKs) that catalyze the phosphorylation of deoxynucleosides to their corresponding deoxynucleoside monophosphates by gamma-phosphoryl transfer of ATP.
María-Jesús, Pérez-Pérez, Ana-Isabel, Hernández, Eva-María, Priego, Fátima, Rodríguez-Barrios, Federico, Gago, María-José, Camarasa, Jan, Balzarini   +6 more
core   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Thymidine Kinase Diversity in Bacteria

Nucleosides, Nucleotides and Nucleic Acids, 2006
Thymidine kinases (TKs) appear to be almost ubiquitous and are found in nearly all prokaryotes, eukaryotes, and several viruses. They are the key enzymes in thymidine salvage and activation of several anti-cancer and antiviral drugs. We show that bacterial TKs can be subdivided into 2 groups. The TKs from Gram-positive bacteria are more closely related
Anders R Clausen, Birgitte Munch-Petersen, Jure Piskur   +2 more
exaly   +4 more sources